Search clinical trials for: Semaglutide 0.5 mg

Total 15312 results

Novo Nordisk A/S

Completed

A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Canada, as Part of Local Clinical Practice (PIONEER REAL)

Diabetes Mellitus, Type 2

Canada
Novo Nordisk A/S

Completed

A Research Study on How Well Semaglutide Works in Adolescents With Overweight or Obesity

Obesity | Overweight

United States, Croatia, Russian Federation, United Kingdom, Belgium, Mexico, Austria, Ireland
Novo Nordisk A/S

Enrolling by invitation

A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Israel, as Part of Local Clinical Practice (PIONEER REAL)

Diabetes Mellitus, Type 2

Israel
University Medical Center Groningen
Novo Nordisk A/S

Enrolling by invitation

SeMaglutide and Albuminuria Reduction Trial in Obese Individuals Without Diabetes (SMART)

Obesity | Albuminuria

Netherlands, Germany, Spain, Canada
Novo Nordisk A/S

Completed

A Clinical Trial Comparing Semaglutide in Healthy People Who Eat and Take the Medicine at Different Times

Healthy Volunteers Type 2 Diabetes

United Kingdom
Novo Nordisk A/S

Completed

A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Japan, as Part of Local Clinical Practice (PIONEER REAL)

Diabetes Mellitus, Type 2

Japan
Novo Nordisk A/S

Completed

Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With Diet and Exercise Only (PIONEER 1)

Diabetes Mellitus, Type 2 | Diabetes

United States, Russian Federation, Mexico, Japan, Serbia, Turkey, Italy, Czechia, Bulgaria, Algeria, Romania
Novo Nordisk A/S

Completed

Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity (STEP 4)

Obesity | Metabolism and Nutrition Disorder

United States, Israel, Spain, Netherlands, Sweden, Switzerland, South Africa, Denmark, Portugal, Ukraine
Novo Nordisk A/S

Completed

A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (C) Semaglutide Tablets

Type 2 Diabetes | Healthy Volunteers

Germany
Novo Nordisk A/S

Completed

Efficacy and Safety of Semaglutide Once-weekly Versus Placebo in Drug-naïve Subjects With Type 2 Diabetes (SUSTAIN™1)

Diabetes Mellitus, Type 2 | Diabetes

United States, United Kingdom, Mexico, Russian Federation, Japan, Canada, Italy, South Africa, Romania
Novo Nordisk A/S

Completed

Pharmacoscintigraphic Investigation of NN9924 in Healthy Male Subjects

Healthy | Diabetes

United Kingdom
Novo Nordisk A/S

Not yet recruiting

SEMA-CardioDiab HUNGARY: A Research Study to Understand the Effects of Oral Semaglutide on Blood Sugar Levels, Weight, and Cardiovascular Risk in People With Type 2 Diabetes Patients in Hungary

Type 2 Diabetes
Novo Nordisk A/S

Recruiting

A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Saudi Arabia, as Part of Local Clinical Practice (PIONEER REAL)

Diabetes Mellitus, Type 2

Saudi Arabia
Novo Nordisk A/S

Completed

A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Switzerland, as Part of Local Clinical Practice (PIONEER REAL)

Diabetes Mellitus, Type 2

Switzerland
Novo Nordisk A/S

Completed

A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in the United Kingdom, as Part of Local Clinical Practice (PIONEER REAL)

Diabetes Mellitus, Type 2

United Kingdom
Novo Nordisk A/S

Completed

A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Italy, as Part of Local Clinical Practice (PIONEER REAL)

Diabetes Mellitus, Type 2

Italy
Novo Nordisk A/S

Completed

Research Study Comparing New Tablets of Semaglutide in New Doses, in Healthy People

Diabetes Mellitus, Type 2

Germany
San Francisco Veterans Affairs Medical Center

Suspended

Semaglutide to Reduce Atrial Fibrillation Burden

Obesity | Overweight | Atrial Fibrillation

United States
Novo Nordisk A/S

Completed

A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (D) Semaglutide Tablets

Type 2 Diabetes | Healthy Volunteers

Germany
Novo Nordisk A/S

Completed

A Trial Investigating the Cardiovascular Safety of Oral Semaglutide in Subjects With Type 2 Diabetes (PIONEER 6)

Diabetes Mellitus, Type 2 | Diabetes

United States, India, Israel, Italy, Mexico, United Kingdom, Canada, Denmark, Spain, Netherlands, Malaysia, Taiwan, Germany, Poland, Turkey, Argentina, South Africa, Romania, Thailand, Algeria, Brazil
Novo Nordisk A/S

Completed

A Research Study to Look at How Semaglutide Affects Gastric Emptying in People With Obesity

Obesity | Overweight

Germany
Novo Nordisk A/S

Completed

A Trial Investigating the Effect of Oral Semaglutide Compared With Placebo on Postprandial Glucose and Triglyceride Metabolism, Energy Intake, Appetite Sensations and Gastric Emptying in Subjects With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

United Kingdom
Novo Nordisk A/S

Completed

Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment (PIONEER 5)

Diabetes Mellitus, Type 2 | Diabetes

United States, Israel, Poland, Russian Federation, United Kingdom, Denmark, Finland, Sweden
Novo Nordisk A/S

Completed

A Trial to Assess the Pharmacokinetics, Pharmacodynamics, and the Safety and Tolerability of Semaglutide in Healthy Male Japanese and Caucasian Subjects

Healthy | Diabetes Mellitus, Type 2 | Diabetes

Japan
Novo Nordisk A/S

Completed

A Trial Investigating the Effects of Semaglutide on ß-cell Function in Subjects With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

Germany
SocraTec R&D GmbH
SocraMetrics GmbH; Glatt Pharmaceutical Services GmbH & Co. KG

Completed

Cannabidiol Bioavailability Trial With Oral Multiple Dose Administration

Comparative Bioavailability

Germany
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Bioequivalence Study of 3 New Formulations of Premarin/MPA Compared With Premarin/MPA (Prempro)

Postmenopause

United States
GangaGen, Inc.

Completed

Safety & Efficacy of an Antibacterial Protein Molecule Applied Topically to the Nostrils of Volunteers and Patients

Bacterial Infections | Infectious Disease

Singapore
Eisai Inc.
Biogen

Active, not recruiting

A Study to Evaluate Safety, Tolerability, and Efficacy of Lecanemab in Subjects With Early Alzheimer's Disease

Alzheimer's Disease

United States, Canada, France, Germany, Italy, Japan, Korea, Republic of, Netherlands, Spain, Sweden, United Kingdom
McGill University Health Centre/Research Institute...
Centre de Recherche du Centre Hospitalier de l'Université de Montréal; CIHR... and other collaborators

Terminated

Cannabinoids in PLWHIV on Effective ART

HIV Infections

Canada
GlaxoSmithKline

Terminated

A Study to Evaluate Single and Repeat Doses of IV GSK2251052 in Healthy Male Japanese and Caucasian Subjects and Repeat Doses of Supratherapeutic Doses of IV GSK2251052 in Healthy Volunteers

Community-acquired Infection

United States
Southeast Retina Center, Georgia
Genentech, Inc.

Completed

Safety Study of 2.0mg Lucentis to Treat Polypoidal Choroidal Vasculopathy

Polypoidal Choroidal Vasculopathy

United States
Centro Hospitalar do Porto

Completed

Effect of the Vitreous in Response to Intravitreal Injections of Ranibizumab for the Treatment of Diabetic Macular Edema (DEVITRA)

Diabetic Macular Edema

Portugal
University Hospital Muenster
Vifor Pharma

Terminated

Intravenous Ferric Carboxymaltose (Ferinject) in Patients Undergoing Orthopaedic Surgery (PRIVIRON)

Anemia | Orthopedic Surgery | High Risk of Blood Loss

Germany
AM-Pharma

Completed

Pilot Trial of Single Dose Ilofotase Alfa in Hypophosphatasia

Hypophosphatasia

Germany
Merck Sharp & Dohme LLC

Completed

A Single Dose Study of MK-8266 (MK-8266-001)

Hypertension
Novo Nordisk A/S

Completed

Research Study to Investigate How Well Semaglutide Tablets Taken Once Daily Work in People Who Are Overweight or Living With Obesity (OASIS 1) (OASIS 1)

Obesity | Overweight

Germany, Denmark, Canada, United States, Russian Federation, Finland, Poland, France, Japan
Chinese PLA General Hospital

Unknown

Comparison of the Effects of Repaglinide and Metformin on Glucose Excursions

Type 2 Diabetes

China
McNeil AB

Completed

A Study to Compare Two Formulations of Xylometazoline/Dexpanthenol Nasal Spray for the Treatment of Nasal Congestion.

Nasal Congestion

Russian Federation
Merck Sharp & Dohme LLC

Terminated

An Investigational Drug Study In Patients With COPD (Chronic Obstructive Pulmonary Disease) (MK-0873-005)

Lung Diseases | Pulmonary Disease, Chronic Obstructive
Develi Devlet Hastanesi

Unknown

Evaluation of Duration of Anesthesia and Patient Satisfaction After Retrobulbar Block Applied in Cataract Surgery

Anesthesia, Local | Patient Satisfaction | Anesthesia Recovery Period | Cataract Surgery | Anesthesia; Adverse Effect | Akinesia

Turkey
Tulane University
Louisiana State University Health Sciences Center in New Orleans; Antares Pharma...

Not yet recruiting

Testosterone Treatment for Erectile Dysfunction and Multiple Sclerosis

Multiple Sclerosis | Erectile Dysfunction | Testosterone Deficiency

United States
Pfizer

Completed

A Study To Observe Safety And Blood Concentrations Of PF-04995274 During And Following the Administration of Multiple Doses Of PF-04995274 In Healthy Adult And Healthy Elderly Volunteers.

Healthy

United States
Alembic Pharmaceuticals Ltd.

Completed

Oral Bio-equivalence Study

Bioequivalence | Safety

Canada
Lpath, Inc.

Completed

Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD (Nexus)

Exudative Age-related Macular Degeneration

United States
Pfizer

Withdrawn

A Study To Look At Safety And Blood Concentrations After Multiple Doses Of PF-03382792 In Healthy Elderly Individuals

Healthy
Bioverativ, a Sanofi company

Completed

A Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple- Dose BIVV009 in Participants With Chronic Immune Thrombocytopenia (ITP)

Purpura, Thrombocytopenic, Idiopathic

United Kingdom, United States, Germany
Ann & Robert H Lurie Children's Hospital of Chicago

Withdrawn

Reexamining Hypotonic Intravenous Fluid Use

Hyponatremia

United States
Hyben Vital ApS

Completed

A Double-blind, Randomized, Parallel Group, Fase III Comparative Study With Rose Hip Powder Powder and Placebo Given to Patients With Mild to Moderate Osteoarthritis in the Knee or/and Hip

Quality of Life | Pain | Activities of Daily Living

Denmark
Aldeyra Therapeutics, Inc.

Completed

A Randomized, Double Masked, Clinical Study of Subjects With Dry Eye Syndrome

Dry Eye Syndromes

United States

3

Subscribe